ANGO insider buying and SEC filings, explained
Angiodynamics Inc. · CIK 1275187
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$655K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 28–29, 2026 | Sale | Stephen A Trowbridge (CFO) sold 25,335 shares between Oct 28 and Oct 29 at about $12.26 ($311K). Holdings down 8% to 280,461 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 30, 2026, 4:15 PM ET |
| Jul 30, 2026 | Sale | Warren Nighan JR (SVP Quality and Regulatory) sold 23,370 shares at about $14.72 ($344K). Holdings down 27% to 64,745 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 31, 2026 |
23 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ANGO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.